Long-term efficacy and safety of viltolarsen in the treatment of Duchenne muscular dystrophy

被引：0
|
作者：
Clemens, P. [1 ]
Connolly, A. [2 ]
Harper, A. [3 ]
Mah, J. [4 ]
McDonald, C. [5 ]
Rao, V. [6 ]
Smith, E. [7 ]
Zaidman, C. [8 ]
Nakagawa, T. [9 ]
Hoffman, E. [10 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
[2] Nationwide Childrens Hosp, Columbus, OH USA
[3] Childrens Hosp Richmond, Richmond, VA USA
[4] Univ Calgary, Calgary, AB, Canada
[5] Univ Calif Davis, Sacramento, CA 95817 USA
[6] Lurie Childrens Hosp Chicago, Chicago, IL USA
[7] Duke Univ, Med Ctr, Durham, NC USA
[8] Washington Univ, St Louis, MO 63110 USA
[9] NS Pharma, Paramus, NJ USA
[10] SUNY Binghamton, Sch Pharm, Binghamton, NY USA
来源：
NEUROMUSCULAR DISORDERS | 2021年 / 31卷
关键词：
D O I：
10.1016/j.nmd.2021.07.165
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP.140
引用
收藏
页码：S91 / S91
页数：1
相关论文
共 50 条
  • [41] LONG-TERM OBSERVATION OF CARDIAC-FUNCTION IN DUCHENNE MUSCULAR-DYSTROPHY
    UTSUNOMIYA, T
    SHIMIZU, A
    KURIYA, T
    OKU, Y
    HASHIBA, K
    OGAWA, M
    OH, F
    MORI, K
    MATSUO, S
    NAKAZAWA, Y
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1982, 46 (08): : 858 - 858
  • [42] DUCHENNE MUSCULAR-DYSTROPHY - ETHICAL AND EMOTIONAL CONSIDERATIONS IN LONG-TERM MANAGEMENT
    MENDELL, JR
    VAUGHN, AJ
    SEMINARS IN NEUROLOGY, 1984, 4 (01) : 98 - 103
  • [43] Long-term ventilation for patients with Duchenne muscular dystrophy - Physicians' beliefs and practices
    Gibson, B
    CHEST, 2001, 119 (03) : 940 - 946
  • [44] LONG-TERM BENEFIT FROM PREDNISONE THERAPY IN DUCHENNE MUSCULAR-DYSTROPHY
    FENICHEL, GM
    FLORENCE, JM
    PESTRONK, A
    MENDELL, JR
    MOXLEY, RT
    GRIGGS, RC
    BROOKE, MH
    MILLER, JP
    ROBISON, J
    KING, W
    SIGNORE, L
    PANDYA, S
    SCHIERBECKER, J
    WILSON, B
    NEUROLOGY, 1991, 41 (12) : 1874 - 1877
  • [45] LONG-TERM ELECTROCARDIOGRAPHIC STUDIES IN PATIENTS WITH DUCHENNE PROGRESSIVE MUSCULAR-DYSTROPHY
    LUKASIK, E
    LISZEWSKAPFEJFER, D
    RUBACH, K
    SZWED, H
    ACTA MEDICA POLONA, 1980, 21 (02) : 181 - 191
  • [46] Safety, feasibility, and efficacy of strengthening exercise in Duchenne muscular dystrophy
    Lott, Donovan J.
    Taivassalo, Tanja
    Cooke, Korey D.
    Park, Hyunjun
    Moslemi, Zahra
    Batra, Abhinandan
    Forbes, Sean C.
    Byrne, Barry J.
    Walter, Glenn A.
    Vandenborne, Krista
    MUSCLE & NERVE, 2021, 63 (03) : 320 - 326
  • [47] Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy: A Systematic Review
    Pascual-Morena, Carlos
    Luceron-Lucas-Torres, Maribel
    Martinez-Garcia, Irene
    Rodriguez-Gutierrez, Eva
    Patino-Cardona, Silvana
    Sequi-Dominguez, Irene
    PEDIATRIC DRUGS, 2024, 26 (06) : 695 - 707
  • [48] Viltolarsen: a treatment option for Duchenne muscular dystrophy patients who are amenable to exon 53 skipping therapy
    Czifrus, Eszter
    Berlau, Daniel J. J.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2023, 23 (10) : 853 - 858
  • [49] Evaluating the effect of long-term idebenone treatment on respiratory morbidity in patients with Duchenne muscular dystrophy (DMD)
    Mayer, Oscar Henry
    Leinonen, Mika
    Servais, Laurent
    Straathof, Chiara
    Schara, Ulrike
    Voit, Thomas
    Mercuri, Eugenio
    Buyse, Gunnar
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [50] Glucocorticoid Treatment for the Prevention of Scoliosis in Children with Duchenne Muscular Dystrophy: Long-Term Follow-up
    Lebel, David E.
    Corston, John A.
    McAdam, Laura C.
    Biggar, W. Douglas
    Alman, Benjamin A.
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2013, 95A (12): : 1057 - 1061
12345